Cervarix
Human papillomavirus vaccine (bivalent recombinant, HPV 16/18) · HPV16 L1 20 mcg + HPV18 L1 20 mcg / 0.5 mL dose
Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Human papillomavirus vaccine (bivalent recombinant, HPV 16/18)
- Therapeutic area
- Vaccines & immunologicals
- Drug class
- Vaccines
- ATC
- J07
- Strength
- HPV16 L1 20 mcg + HPV18 L1 20 mcg / 0.5 mL dose
- Dosage form
- Prefilled syringe vaccine injection
- Pack
- 1's
- Registration no.
- 059029
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
GlaxoSmithKline Pakistan Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 8,440.97, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Cervarix HPV16 L1 20 mcg + HPV18 L1 20 mcg / 0.5 mL dose, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/cervarix-hpv16-l1-20-mcg-hpv18-l1-20-mcg-0-5-ml-dose-059029-1s-gsk-pakistan-limited/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 8,440.97 | 2026-07-23 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 059029Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
